P&G Health Sees 7% Sales Growth as PAT Jumps 45%

Procter & Gamble Health (PGHL) posted a 7% year-on-year increase in sales to Rs 356 crore for the quarter ended June 30, 2026. The company's reported profit after tax (PAT) surged 45% to Rs 96 crore.

The growth was driven by resilient consumer demand, stronger retail execution, and encouraging response to new product launches. Excluding a one-time asset sale, operational PAT stood at Rs 72 crore, marking a 9% increase over the corresponding quarter last year.

Managing Director Milind Thatte said the company had entered FY27 with strong momentum, supported by science-backed product innovations and investments in its distribution and supply chain network.